Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Don England who wrote (603)	2/16/2000 10:23:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 673

>> was an absolutely great day. raised cash last week, bought on dips this - ngen, gene, and now have to worry about where to slide some off. if this post makes you feel used, ignore it and i will understand << Don: Your post, start to finish, is what SI Biotech is all about. Used? I'm happy when I'm correct, and it helps someone. Happy when I'm wrong, and there's enough balancing perspective. Let's hang around and do it for another five years or so. Congrats, all! Rick

To: Don England who wrote (603)	2/17/2000 1:12:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 673

>> i would like to know what your take is on the beckonbiotech newsletter's comments on cyto's proteomics division, axcell? << Don..... only reasonably priced game in town? Remarkable turnaround in business plan for the company, glad you got some. Stefaan was beating on me to buy a few days ago, but I was distracted. Reiser (CEO that had one heck of a tough job) is doing well. That said, I don't think that even this relatively cheap play is cheap. I'm waiting for corrections, but I encourage others who have looked more closely at Axcell to chime in and convince me of the error of my ways. Sorry I can't give a clear picture of competitive status versus a CRGN or a MLNM, but I just haven't looked closely enough.